Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income and revenues:    
Income from purchased receivables under the EIR method $ 26,745 $ 15,066
Income from purchased receivables under the cost recovery method 13,744 3,201
Revenue from contracts with customers 10,350 6,650
Revenue recognized under units-of-revenue method 1,310 3,570
Total income and revenues 52,149 28,487
Operating expenses:    
Research and development 1,712 2,875
General and administrative 36,092 34,478
Credit losses on purchased receivables   30,904
Amortization of intangible assets 2,961 206
Total operating expenses 40,765 68,463
Income (loss) from operations 11,384 (39,976)
Other income (expense), net:    
Gains on acquisitions 21,224 19,316
Change in fair value of embedded derivative related to RPA   8,100
Interest expense (13,031) (13,840)
Other income, net 12,238 6,921
Net income (loss) before tax 31,815 (19,479)
Income tax (expense) benefit (103) 5,658
Net income (loss) 31,712 (13,821)
Net income (loss) available to (attributable to) common stockholders, basic 18,516 (19,293)
Net income (loss) available to (attributable to) common stockholders, diluted $ 26,184 $ (19,293)
Net income (loss) per share available to (attributable to) common stockholders, basic (in dollars per share) $ 1.53 $ (1.65)
Net income (loss) per share available to (attributable to) common stockholders, diluted (in dollars per share) $ 1.46 $ (1.65)
Weighted-average shares used in computing net income (loss) per share available to (attributable to) common stockholders, basic (in shares) 12,081 11,701
Weighted-average shares used in computing net income (loss) per share available to (attributable to) common stockholders, diluted (in shares) 17,982 11,701